Report #2837865

Received Apr 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: TX
Recovered: Unknown
Vaccinated: Apr 3, 2025
Onset: Apr 3, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	—	—

Symptoms (1)

Blister

Symptom narrative

blisters on nose and back; This non-serious case was reported by a other health professional via sales rep and described the occurrence of blister in a patient who received Herpes zoster (Shingrix) for prophylaxis. On 03-APR-2025, the patient received the 1st dose of Shingrix. On 03-APR-2025, less than a day after receiving Shingrix, the patient experienced blister (Verbatim: blisters on nose and back). The outcome of the blister was unknown. It was unknown if the reporter considered the blister to be related to Shingrix. It was unknown if the company considered the blister to be related to Shingrix. Additional Information: GSK Receipt Date: 17-APR-2025 Patient had adverse reaction developed blisters on nose and back same date she received first dose of Shingrix on 03 Apr 2025. They asked if they can administer second dose of Shingrix to patient or not.